ALHC - NASDAQ
Alignment Healthcare, Inc.
$14.25
+7.1%Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
At a Glance
Live Snapshotalhc
Total Liabilities
Last Annual Value
886.51M
3-Year CAGR
31%
5-Year CAGR
24%
10-Year CAGR
13%
Alignment Healthcare, Inc. Competitors Analysis of Total Liabilities
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Alignment Healthcare, Inc. NASDAQ:ALHC | 886.51M | 26.9% | 22.2% | N/A | |
 Envista Holdings Corp NYSE:NVST | 2.57B | 1.9% | 0.4% | N/A | |
 Privia Health Group, Inc. NASDAQ:PRVA | 578.43M | 13.8% | 19.6% | N/A | |
 Ultragenyx Pharmaceutical Inc. NASDAQ:RARE | 1.60B | 9.7% | 21.8% | 37.5% | |
 Soleno Therapeutics, Inc. NASDAQ:SLNO | 113.72M | 69.9% | 45.0% | 48.9% | |
 Apogee Therapeutics, Inc. NASDAQ:APGE | 33.25M | 15.7% | N/A | N/A | |
 Dyne Therapeutics, Inc. NASDAQ:DYN | 214.83M | 42.8% | 30.2% | -32.5% | |
 Mirum Pharmaceuticals, Inc. NASDAQ:MIRM | 528.12M | 9.9% | 24.8% | N/A | |
 ICU Medical, Inc. NASDAQ:ICUI | 1.93B | -5.1% | 48.7% | 45.8% | |
 Oscar Health, Inc. NYSE:OSCR | 5.34B | 24.1% | 22.6% | N/A | |
 GRAIL, Inc. NASDAQ:GRAL | 344.15M | -27.7% | 2.3% | N/A |
Alignment Healthcare, Inc. Fair Value Envelope
Related Guides
Continue your ALHC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.